Aytu BioPharma Inc.
AYTU | NASDAQ
$2.29
+$0.17 (+7.76%)
Sep 22, 2026, 11:58 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 | FY 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | 66.38M | 65.18M | 107.4M | 96.67M | 65.63M | 27.63M |
Cost of Revenue | 20.55M | 16.13M | 40.77M | 46.39M | 36.43M | 8.28M |
Gross Profit | 45.83M | 49.05M | 66.63M | 50.28M | 29.2M | 19.35M |
Operating Income | -7.83M | -1.59M | -17.07M | -109.91M | -58.87M | -21.13M |
Interest Income | n/a | n/a | n/a | 14K | n/a | n/a |
Pretax Income | -13.75M | -10.38M | -17.05M | -108.89M | -58.03M | -13.62M |
Net Income | -13.56M | -15.84M | -17.05M | -108.78M | -58.29M | -13.62M |
Selling & General & Admin | 38.29M | 42.04M | 70.08M | 69.88M | 55.81M | 31.06M |
Research & Development | 1.33M | 2.77M | 4.1M | 12.66M | 5.62M | 1.72M |
Other Expenses | 14.05M | 5.84M | 9.52M | 77.65M | 26.64M | 7.7M |
Operating Expenses | 53.66M | 50.65M | 83.7M | 160.19M | 88.07M | 40.48M |
Interest Expense | 3.7M | 4.79M | 4.96M | 147.5M | n/a | n/a |
Selling & Marketing Expenses | 20.91M | 22.08M | 41.45M | 38.71M | 30.31M | 11.4M |
Cost & Expenses | 74.21M | 66.77M | 124.46M | 206.58M | 124.5M | 48.76M |
Income Tax Expense | 437K | 2.14M | n/a | -110K | 259K | n/a |
Shares Outstanding (Basic) | 6.28M | 5.54M | 3.34M | 1.47M | 840K | 230K |
Shares Outstanding (Diluted) | 6.28M | 5.54M | 3.34M | 1.47M | 840K | 230K |
EPS (Basic) | -2.16 | -2.86 | -5.11 | -74.01 | -69.60 | -60.20 |
EPS (Diluted) | -2.16 | -2.86 | -5.11 | -74.01 | -69.60 | -60.20 |
EBITDA | -4.67M | 1.41M | -3.27M | -27.96M | -29.04M | -12.21M |
EBIT | -10.04M | -5.32M | -12.09M | -38.1M | -38.24M | -17.92M |
Depreciation & Amortization | 5.38M | 6.73M | 8.82M | 10.15M | 9.2M | 5.71M |
Add to Watchlist
Select watchlists to add or remove AYTU